Scalpel Weekly News

Week of: March 03, 2014

IN THE NEWS


Tracheal Tube Recalled; Potential Kinking During Patient Use

Teleflex Medical of Research Triangle Park, NC, sent their customers an Urgent Medical Device Recall Notification about its ISIS HVT Tracheal Tube Cuffed with Subglottic Secretion Suction Port (with and without Preloaded Stylet). Click title to continue reading...  


 
MEDICAL ALERTS


FDA Orders Manufacturer to Stop Sale of Tobacco Products

The FDA issued orders to stop the further sale and distribution of four tobacco products currently on the market. The action marks the first time the FDA has used its authority under the Family Smoking Prevention and Tobacco Control Act to order a manufacturer of currently available tobacco products to stop selling and distributing them. Click title to continue reading...



Blood Vessel Guidewire Recalled; Coating May Flake Causing Injury

The FDA issued a Class I recall for ACME Monaco Guidewire .035x150 3MMJ TCFC, item number 88241, manufactured by Medline Industries, Inc. Click title to continue reading...



Flu Hits Younger People Particularly Hard This Season

This influenza season was particularly hard on younger- and middle-age adults. People age 18-64 represented 61 percent of all hospitalizations from influenza. Click title to continue reading...


  CASE ALERTS


Stent Not Timely Removed Tolls Limitations Under Foreign Body Exception

A man was injured by a gunshot and he underwent emergency abdominal surgery to repair the injury. During the procedure, surgeons implanted a biliary stent. The man was unconscious or otherwise incapacitated secondary to his injuries when the stent was implanted. Click title to continue reading... 



Blood Pressure Catheter in Heart 22 Years Not Foreign Object; Exception Not Applicable

A three-year-old boy underwent heart surgery. During the surgery, polyvinyl catheters were placed inside his heart to record atrial pressure. Three days later, a follow-up procedure was performed to remove the catheters. Click title to continue reading... 



$193M Settlement for Promoting Lidoderm for Unapproved Uses

Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the FDA. Click title to continue reading...